Transforming growth factor-beta1 null mutation causes infertility in male mice associated with testosterone deficiency and sexual dysfunction.
TGFbeta1 is a multifunctional cytokine implicated in gonad and secondary sex organ development, steroidogenesis, and spermatogenesis. To determine the physiological requirement for TGFbeta1 in male reproduction, Tgfb1 null mutant mice on a Prkdc(scid) immunodeficient background were studied. TGFbeta1-deficient males did not deposit sperm or induce pseudopregnancy in females, despite an intact reproductive tract with morphologically normal penis, seminal vesicles, and testes. Serum and intratesticular testosterone and serum androstenedione were severely diminished in TGFbeta1-deficient males. Testosterone deficiency was secondary to disrupted pituitary gonadotropin secretion because serum LH and to a lesser extent serum FSH were reduced, and exogenous LH replacement with human chorionic gonadotropin (hCG) induced serum testosterone to control levels. In the majority of TGFbeta1-deficient males, spermatogenesis was normal and sperm were developmentally competent as assessed by in vitro fertilization. Analysis of sexual behavior revealed that although TGFbeta1 null males showed avid interest in females and engaged in mounting activity, intromission was infrequent and brief, and ejaculation was not attained. Administration of testosterone to adult males, even after neonatal androgenization, was ineffective in restoring sexual function; however, erectile reflexes and ejaculation could be induced by electrical stimulation. These studies demonstrate the profound effect of genetic deficiency in TGFbeta1 on male fertility, implicating this cytokine in essential roles in the hypothalamic-pituitary-gonadal axis and in testosterone-independent regulation of mating competence.
Ingman
Wendy V
WV
Discipline of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, Adelaide, South Australia 5005, Australia.
Robertson
Sarah A
SA
D000728:Androgens / Q000097:blood / Q000172:deficiency* / Q000494:pharmacology; D000735:Androstenedione / Q000097:blood; D000818:Animals; D004542:Ejaculation / Q000187:drug effects / Q000502:physiology; D004558:Electric Stimulation; D004958:Estradiol / Q000097:blood; D005260:Female; D007248:Infertility, Male / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008817:Mice, Mutant Strains; D009154:Mutation; D010410:Penile Erection / Q000187:drug effects / Q000502:physiology; D011247:Pregnancy; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology; D013737:Testis / Q000378:metabolism / Q000473:pathology; D013739:Testosterone / Q000097:blood / Q000172:deficiency* / Q000494:pharmacology; D053773:Transforming Growth Factor beta1 / Q000235:genetics* / Q000502:physiology*
D000728:Androgens; D053773:Transforming Growth Factor beta1; D013739:Testosterone; D000735:Androstenedione; D004958:Estradiol